These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2876724)

  • 1. The antisecretory effects of zaltidine, a novel long-acting H2-receptor antagonist, in healthy volunteers and in subjects with a past history of duodenal ulcer.
    Laferla G; Buchanan N; Hearns J; Crean GP; McColl KE; Clucas AT
    Br J Clin Pharmacol; 1986 Oct; 22(4):395-9. PubMed ID: 2876724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zaltidine: an effective but hepatotoxic H2-receptor antagonist.
    Farup PG
    Scand J Gastroenterol; 1988 Aug; 23(6):655-8. PubMed ID: 2902681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of mifentidine on the secretory response to sham feeding and pentagastrin and on serum gastrin in duodenal ulcer patients.
    Bianchi Porro G; Lazzaroni M; Imbimbo BP; Sangaletti O; Ghirardosi C; Daniotti S
    Eur J Clin Pharmacol; 1987; 32(6):555-8. PubMed ID: 2888658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new histamine H2-receptor antagonist ranitidine. Duration of action.
    Dammann HG; Simon B
    Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of various dose regimens of famotidine on basal nocturnal and meal-stimulated gastric secretion.
    Ryan JR; Chremos AN; Vargas R; Mantell G; Johnson CL; McMahon FG
    Clin Pharmacol Ther; 1987 Aug; 42(2):225-31. PubMed ID: 2886245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiotidine, a new long-acting histamine H2-receptor antagonist: comparison with cimetidine.
    Richardson CT; Feldman M; Brater C; Welborn J
    Gastroenterology; 1981 Feb; 80(2):301-6. PubMed ID: 6108895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisecretory activity of pirenzepine versus cimetidine in man: a controlled study.
    Procacciante F; Citone G; Montesani C; Ribotta G
    Gut; 1984 Feb; 25(2):178-82. PubMed ID: 6546371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric acid secretion stimulated by modified sham-feeding, and the effects of histamine H2-antagonist and anti-muscarinic agent in patients with duodenal ulcer.
    Ooi S; Kaneko E
    Gastroenterol Jpn; 1989 Oct; 24(5):505-11. PubMed ID: 2572505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of gastric acid inhibition by ranitidine in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Digestion; 1981; 22(3):119-25. PubMed ID: 6116636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human gastric secretion by ICI 162,846--a new histamine H2-receptor antagonist.
    Wilson JA; Johnston DA; Penston J; Wormsley KG
    Br J Clin Pharmacol; 1986 Jun; 21(6):685-9. PubMed ID: 2874823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study with ranitidine and cimetidine on gastric secretion in normal volunteers.
    Sewing KF; Billian A; Malchow H
    Gut; 1980 Sep; 21(9):750-2. PubMed ID: 6107265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxmetidine: clinical pharmacological studies with a new H2-receptor antagonist.
    Mills JG; Brunet PL; Griffiths R; Hunt RH; Vincent D; Milton-Thompson GJ; Burland WL
    Gut; 1982 Feb; 23(2):157-63. PubMed ID: 6121744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of gastric acid secretion by intravenous amino acid infusion and its inhibition by H2-receptor antagonists ranitidine and cimetidine.
    Weingart J; Kunert H; Ottenjann R
    Scand J Gastroenterol Suppl; 1981 Jun; 69():61-5. PubMed ID: 6119784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study with ranitidine and cimetidine on gastric secretion.
    Sewing KF; Billian A; Malchow H
    Scand J Gastroenterol Suppl; 1981 Jun; 69():45-9. PubMed ID: 6119782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K; Kato S; Yamamoto H; Okabe S
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.
    Walt RP; Male PJ; Rawlings J; Hunt RH; Milton-Thompson GJ; Misiewicz JJ
    Gut; 1981 Jan; 22(1):49-54. PubMed ID: 6109686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology of famotidine: a summary.
    Chremos AN
    J Clin Gastroenterol; 1987; 9 Suppl 2():7-12. PubMed ID: 2887616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of famotidine.
    Smith JL
    Digestion; 1985; 32 Suppl 1():15-23. PubMed ID: 2866132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.